Description
The Side Effects of Drugs Annual was first published in 1977. It has been published continuously since then, as a yearly update to the encyclopaedic volume Meyler's Side Effects of Drugs. Each new Annual provides clinicians and medical investigators with a reliable and critical yearly survey of new data and trends in the area of Adverse Drug Reactions and Interactions.
An international team of specialists have contributed to the Annuals by selecting critically from each year's publications all that is truly new and informative, by critically interpreting it, and by pointing out whatever is misleading. The use of the book is enhanced by separate indexes, allowing the reader to enter the text via the drug name, adverse effect, or drug interaction.
Special features of the Annuals are the Side Effects of Drugs Essay, usually written by a guest author, and the special reviews: short articles, within the different chapters, that give extra attention to topics of current interest.
The Essay in Annual 26 is entitled 'How safe is cannabis?' (by Professor L.L. Iversen) and there is a Historical Essay entitled 'From thalidomide to pharmacovigilance: a personal account' (by Professor D.J. Finney).
The special reviews in this volume include, among others:
- The cognitive effects of Ecstasy
- Antipsychotic drugs and weight gain
- Vigabatrin-related visual abnormalities
- Managing the adverse ef
Chapter
Essay: How safe is cannabis?
pp.：
34 – 50
Chapter 1. Central nervous system stimulants and drugs that suppress appetite
pp.：
50 – 60
Chapter 2. Antidepressant drugs
pp.：
60 – 68
Chapter 3. Lithium
pp.：
68 – 79
Chapter 4. Drugs of abuse
pp.：
79 – 95
Chapter 5. Hypnosedatives and anxiolytics
pp.：
95 – 102
Chapter 6. Antipsychotic drugs
pp.：
102 – 119
Chapter 7. Antiepileptic drugs
pp.：
119 – 138
Chapter 8. Opioid analgesics and narcotic antagonists
pp.：
138 – 160
Chapter 9. Anti-inflammatory and antipyretic analgesics and drugs used in gout
pp.：
160 – 180
Chapter 10. General anesthetics and therapeutic gases
pp.：
180 – 189
Chapter 11. Local anesthetics
pp.：
189 – 199
Chapter 12. Neuromuscular blocking agents and skeletal muscle relaxants
pp.：
199 – 205
Chapter 13. Drugs that affect autonomic functions or the extrapyramidal system
pp.：
205 – 217
Chapter 14. Dermatological drugs and topical agents
pp.：
217 – 229
Chapter 15. Antihistamines (H1 receptor antagonists)
pp.：
229 – 235
Chapter 16. Drugs acting on the respiratory tract
pp.：
235 – 247
Chapter 17. Positive inotropic drugs and drugs used in dysrhythmias
pp.：
247 – 272
Chapter 18. Beta-adrenoceptor antagonists and antianginal drugs
pp.：
272 – 279
Chapter 19. Drugs acting on the cerebral and peripheral circulations
pp.：
279 – 282
Chapter 20. Antihypertensive drugs
pp.：
282 – 287
Chapter 21. Diuretics
pp.：
287 – 292
Chapter 22. Metals
pp.：
292 – 302
Chapter 23. Metal antagonists
pp.：
302 – 307
Chapter 24. Antiseptic drugs and disinfectants
pp.：
307 – 311
Chapter 25. Penicillins, cephalosporins, other beta-lactam antibiotics, and tetracyclines
pp.：
311 – 320
Chapter 26. Miscellaneous antibacterial drugs
pp.：
320 – 351
Chapter 27. Antifungal drugs
pp.：
351 – 364
Chapter 28. Antiprotozoal drugs
pp.：
364 – 377
Chapter 29. Antiviral drugs
pp.：
377 – 388
Chapter 30. Drugs used in tuberculosis and leprosy
pp.：
388 – 393
Chapter 31. Antihelminthic drugs
pp.：
393 – 402
Chapter 32. Vaccines
pp.：
402 – 412
Chapter 33. Blood, blood components, plasma, and plasma products
pp.：
412 – 423
Chapter 34. Intravenous infusions—solutions and emulsions
pp.：
423 – 428
Chapter 35. Drugs affecting blood coagulation, fibrinolysis, and hemostasis
pp.：
428 – 431
Chapter 36. Gastrointestinal drugs
pp.：
431 – 442
Chapter 37. Drugs acting on the immune system
pp.：
442 – 465
Chapter 38. Vitamins
pp.：
465 – 476
Chapter 39. Corticotrophins, corticosteroids, and prostaglandins
pp.：
476 – 483
Chapter 40. Sex hormones and related compounds, including hormonal contraceptives
pp.：
483 – 506
Chapter 41. Thyroid hormones and antithyroid drugs
pp.：
506 – 510
Chapter 42. Insulin, glucagon, and hypoglycemic drugs
pp.：
510 – 526
Chapter 43. Miscellaneous hormones
pp.：
526 – 535
Chapter 44. Drugs that affect lipid metabolism
pp.：
535 – 539
Chapter 45. Cytostatic drugs
pp.：
539 – 561
Chapter 46. Radiological contrast agents
pp.：
561 – 574
Chapter 47. Drugs used in ocular treatment
pp.：
574 – 577
Chapter 48. Treatments used in complementary and alternative medicine
pp.：
577 – 589
Chapter 49. Miscellaneous drugs, materials, and medical devices
pp.：
589 – 597
Chapter 50. The WHO International Drug Monitoring Programme
pp.：
597 – 608
Address list of national centres that participate in the WHO Drug Monitoring Programme
pp.：
608 – 620
Index of drugs
pp.：
620 – 634
Index of adverse effects
pp.：
634 – 663
Side Effects of Drugs Annual
：A world-wide yearly survey of new data and trends in adverse drug reactions
( Volume 26 )
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
